Turmeric can fight colon cancer
March 3rd, 2011 - 4:06 pm ICT by IANSLondon, March 3 (IANS) Curcumin, an active ingredient of turmeric, can fight colon cancer when used in combination with a popular anti-inflammatory drug, say researchers.
A treatment based on this finding has had promising results in human clinical trials, the journal Therapeutic Advances in Gastroenterology reports.
Several lines of evidence demonstrate that chronic inflammation in the stomach can cause gastric cancer and that inflammation in the liver from hepatitis can lead to liver cancer, according to a Tel Aviv statement.
“Although more testing will be needed before a possible new drug treatment is developed. One could combine curcumin with a lower dose of a cancer anti-inflammatory drug, to better fight colon cancer,” says Shahar Lev-Ari from Tel Aviv University, Israel.
Lev-Ari found that Celecoxib, a popular drug commonly used to treat arthritis, also inhibits proliferation of colon cancer in lab settings.
Curcumin increases the anti-cancer and anti-inflammatory effects of Celecoxib while reducing its dose, thus reducing its toxic side-effects, including the rate of heart attack and stroke.
- Turmeric 'the right spice' to fight colon cancer - Mar 03, 2011
- Tumeric derivative found promising in tendinitis - Aug 11, 2011
- Turmeric lowers heart attack risk post surgery - Apr 16, 2012
- Cell killer enzyme could help cancer treatment - Mar 06, 2011
- Widely used arthritis pill shows promise against skin cancer - Dec 03, 2010
- Estrogen found to protect against gastric cancer - Jul 18, 2011
- New aspirin curbs 11 kinds of cancer, shrinks tumours - Mar 09, 2012
- New signaling pathway linked to inflammatory disease discovered - Dec 15, 2010
- Curcumin could slow liver disease: Study - Mar 26, 2010
- Coffee can cure hepatitis C - Jun 08, 2011
- Beware! Pain killers could spike your BP - Mar 21, 2012
- Latin brew bumps off colon cancer cells - Jan 24, 2012
- Study examines aspirin's ability to protect against colorectal cancer - Mar 10, 2011
- Drug combo helps protect hearing - Feb 24, 2011
- Aspirin, ibuprofen offer no protection against skin cancer - Feb 16, 2010
Tags: active ingredient, ari, celecoxib, chronic inflammation, colon cancer, gastric cancer, heart attack, hepatitis, human clinical trials, inflammatory drug, lab settings, liver cancer, london march, proliferation, promising results, shahar, tel aviv university, tel aviv university israel, therapeutic advances, toxic side effects